Antibodies useful in passive influenza immunization
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 19, 2020
Grant Date -
Oct 30, 2014
app pub date -
Dec 5, 2012
filing date -
Dec 5, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
Specific monoclonal antibodies and fragments including bispecific antibodies thereof that are crossreactive with multiple clades of influenza virus including both Group 1 and Group 2 representatives are disclosed. These antibodies are useful in controlling influenza epidemics and pandemics as well as in providing prophylactic or therapeutic protection against seasonal influenza.
First Claim
Other Claims data not available
Family
Loading Family data...
International Classification(s)
- 2012 Application Filing Year
- A61K Class
- 11964 Applications Filed
- 9694 Patents Issued To-Date
- 81.03 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 5 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Nov 19, 2027 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Nov 19, 2031 |
